mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.6 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |